Background: Polymerase chain reaction (PCR) is an extremely sensitive method that often demands optimization, especially when difficult templates need to be amplified. The aim of the present study was to optimize the PCR conditions for amplification of the epidermal growth factor receptor (EGFR) promoter sequence featuring an extremely high guanine-cytosine (GC) content in order to detect single nucleotide polymorphisms -216G>T and -191C>A. Methods: Genomic DNA used for amplification was extracted from formalin-fixed paraffin-embedded lung tumor tissue and PCR products were detected by agarose gel electrophoresis. Results: Results showed that addition of 5% dimethyl sulfoxide (DMSO), as well as DNA concentration in PCR reaction of at least ...
The presence of activating mutations in the EGFR gene influences cell proliferation, angiogenesis, a...
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Epideral growth factor re...
Non-small-cell lung cancer (NSCLC) accounts for 80% of lung cancer and has a 5 year survival rate of...
BackgroundPolymerase chain reaction (PCR) is an extremely sensitive method that often demands optimi...
Highly sensitive genotyping techniques are useful to detect epidermal growth factor receptor (EGFR) ...
AbstractDigital PCR offers very high sensitivity compared to many other technologies for processing ...
Epidermal growth factor receptor (EGFR) is an important mediator of tumor cell survival and prolifer...
Introduction:Detection of epidermal growth factor receptor (EGFR) mutations is indispensable to dete...
Digital PCR offers very high sensitivity compared to many other technologies for processing molecula...
Abstract Epidermal growth factor receptor (EGFR) kinase domain mutations hyperactivate the kinase an...
The objective of this study is to compare two EGFR testing methodologies (a commercial real-time PCR...
The objective of this study is to compare two EGFR testing methodologies (a commercial real-time PCR...
BACKGROUND: Precision medicine trials targeting the epidermal growth factor receptor (EGFR) in gliob...
Epidermal growth factor receptor (EGFR) gene mutational analysis is critical for guiding the treatme...
PCR is an effective and widely used method for the amplification of target DNA fragments in vitro. T...
The presence of activating mutations in the EGFR gene influences cell proliferation, angiogenesis, a...
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Epideral growth factor re...
Non-small-cell lung cancer (NSCLC) accounts for 80% of lung cancer and has a 5 year survival rate of...
BackgroundPolymerase chain reaction (PCR) is an extremely sensitive method that often demands optimi...
Highly sensitive genotyping techniques are useful to detect epidermal growth factor receptor (EGFR) ...
AbstractDigital PCR offers very high sensitivity compared to many other technologies for processing ...
Epidermal growth factor receptor (EGFR) is an important mediator of tumor cell survival and prolifer...
Introduction:Detection of epidermal growth factor receptor (EGFR) mutations is indispensable to dete...
Digital PCR offers very high sensitivity compared to many other technologies for processing molecula...
Abstract Epidermal growth factor receptor (EGFR) kinase domain mutations hyperactivate the kinase an...
The objective of this study is to compare two EGFR testing methodologies (a commercial real-time PCR...
The objective of this study is to compare two EGFR testing methodologies (a commercial real-time PCR...
BACKGROUND: Precision medicine trials targeting the epidermal growth factor receptor (EGFR) in gliob...
Epidermal growth factor receptor (EGFR) gene mutational analysis is critical for guiding the treatme...
PCR is an effective and widely used method for the amplification of target DNA fragments in vitro. T...
The presence of activating mutations in the EGFR gene influences cell proliferation, angiogenesis, a...
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Epideral growth factor re...
Non-small-cell lung cancer (NSCLC) accounts for 80% of lung cancer and has a 5 year survival rate of...